physostigmine has been researched along with Drug Withdrawal Symptoms in 32 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 26 (81.25) | 18.7374 |
1990's | 4 (12.50) | 18.2507 |
2000's | 2 (6.25) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eyer, F; Jetzinger, E; Pfab, R; Zilker, T | 1 |
Freed, WJ; Luchins, DJ; Wyatt, RJ | 1 |
Alphs, LD; Davis, JM | 1 |
Katz, JL; Valentino, RJ | 1 |
Ducardus, R; Dworacek, B; Dzoljic, MR; Rupreht, J; Schmitz, PI | 1 |
Ghosh, MN; Gopalakrishnan, V; Padmanabha Pillai, N; Ramaswamy, S | 1 |
Daunderer, M | 1 |
el-Kadi, AO; Sharif, SI | 1 |
Li, Z; Pei, G; Wu, CF; Xu, NJ | 1 |
Contreras, E; Quijada, L; Tamayo, L | 1 |
Cowan, A | 1 |
Fink, H; Oelssner, W | 1 |
Bhargava, HN; Way, EL | 1 |
Frederickson, RC; Pinsky, C | 1 |
Frederickson, RC | 1 |
Britton, KT; Hauger, R; Irwin, M; Koob, GF; Pulvirenti, L; Swerdlow, NR | 1 |
Brede, S; Dennhardt, R | 1 |
Ignar, DM; Kuhn, CM | 1 |
Backon, J | 1 |
Bilikiewicz, A; Stojek, A; Wolny, S | 1 |
Bilikiewicz, A; Napierala, K; Stojek, A | 1 |
Gothóni, P | 2 |
Brase, DA; Dewey, WL; Tucker, S; Widman, M | 1 |
Gonzalez, LP | 1 |
Goldstein, DB | 1 |
Bell, S; Jhamandas, K; Sutak, M | 1 |
Hayashi, G; Maruyama, Y; Smits, SE; Takemori, AE | 1 |
Modestin, J | 1 |
Ho, IK; Iwamoto, ET; Loh, HH; Way, EL; Wei, E | 1 |
Ho, IK; Iwamoto, ET; Way, EL | 1 |
Holtzman, SG; Villarreal, JE | 1 |
1 review(s) available for physostigmine and Drug Withdrawal Symptoms
Article | Year |
---|---|
Cholinergic treatments for tardive dyskinesia.
Topics: Acetylcholine; Antipsychotic Agents; Choline; Clinical Trials as Topic; Corpus Striatum; Deanol; Dopamine; Dyskinesia, Drug-Induced; Humans; Parasympathomimetics; Phosphatidylcholines; Physostigmine; Research Design; Substance Withdrawal Syndrome | 1983 |
3 trial(s) available for physostigmine and Drug Withdrawal Symptoms
Article | Year |
---|---|
Cholinergic treatments for tardive dyskinesia.
Topics: Acetylcholine; Antipsychotic Agents; Choline; Clinical Trials as Topic; Corpus Striatum; Deanol; Dopamine; Dyskinesia, Drug-Induced; Humans; Parasympathomimetics; Phosphatidylcholines; Physostigmine; Research Design; Substance Withdrawal Syndrome | 1983 |
Studies on the relationship between 5-hydroxytryptamine turnover in brain and tolerance and physical dependence in mice.
Topics: Animals; Aspirin; Brain; Cyclazocine; Drug Tolerance; Fenclonine; Humans; Levorphanol; Male; Methadone; Mice; Morphinans; Morphine; Morphine Dependence; Nalorphine; Pargyline; Pentazocine; Phenylalanine; Physostigmine; Placebos; Serotonin; Substance Withdrawal Syndrome | 1971 |
[Pathogenesis of delirious states].
Topics: Adult; Aged; Alcoholism; Clinical Trials as Topic; Delirium; Drug Evaluation; Female; Humans; Male; Mental Disorders; Middle Aged; Physostigmine; Psychoses, Substance-Induced; Substance Withdrawal Syndrome; Substance-Related Disorders; Tranquilizing Agents | 1974 |
29 other study(ies) available for physostigmine and Drug Withdrawal Symptoms
Article | Year |
---|---|
Withdrawal from high-dose tranylcypromine.
Topics: Adult; Antidotes; Delirium; Heroin Dependence; Humans; Infusions, Intravenous; Male; Migraine Disorders; Monoamine Oxidase Inhibitors; Physostigmine; Substance Withdrawal Syndrome; Thrombocytopenia; Tranylcypromine | 2008 |
The role of cholinergic supersensitivity in the medical symptoms associated with withdrawal of antipsychotic drugs.
Topics: Animals; Antiparkinson Agents; Antipsychotic Agents; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Mice; Physostigmine; Receptors, Cholinergic; Receptors, Muscarinic; Seizures; Substance Withdrawal Syndrome | 1980 |
The opiate quasiwithdrawal syndrome in rhesus monkeys: comparison of naloxone-precipitated withdrawal to effects of cholinergic agents.
Topics: Animals; Behavior, Animal; Cyclazocine; Female; Humans; Macaca mulatta; Male; Morphine Dependence; Naloxone; Parasympathomimetics; Physostigmine; Substance Withdrawal Syndrome | 1984 |
The involvement of the central cholinergic and endorphinergic systems in the nitrous oxide withdrawal syndrome in mice.
Topics: Animals; Brain; Endorphins; Galantamine; Humans; Male; Mice; Naloxone; Nitrous Oxide; Parasympathetic Nervous System; Physostigmine; Seizures; Substance Withdrawal Syndrome | 1983 |
Effect of cholinergic drugs on acute and chronic morphine dependence.
Topics: Animals; Atropine; Humans; Male; Mice; Morphine Dependence; Naloxone; Neostigmine; Parasympathomimetics; Physostigmine; Substance Withdrawal Syndrome; Tubocurarine | 1982 |
Physostigmine salicylate as an antidote.
Topics: Alcohol Withdrawal Delirium; Antidotes; Humans; Parasympatholytics; Physostigmine; Substance Withdrawal Syndrome | 1980 |
The role of cholinergic systems in the expression of morphine withdrawal.
Topics: Animals; Atropine; Behavior, Animal; Body Temperature; Cholinesterase Inhibitors; Drug Interactions; Male; Mice; Morphine; Muscarinic Antagonists; Naloxone; Narcotic Antagonists; Narcotics; Physostigmine; Substance Withdrawal Syndrome | 1996 |
Reversal of morphine-induced memory impairment in mice by withdrawal in Morris water maze: possible involvement of cholinergic system.
Topics: Animals; Cholinergic Antagonists; Dose-Response Relationship, Drug; Injections, Subcutaneous; Male; Maze Learning; Memory Disorders; Mice; Morphine; Motivation; Muscarinic Agonists; Muscarinic Antagonists; Naloxone; Narcotic Antagonists; Narcotics; Oxotremorine; Parasympathetic Nervous System; Physostigmine; Scopolamine; Substance Withdrawal Syndrome | 2001 |
Partial inhibition of the abstinence syndrome in morphine tolerant-dependent mice following pharmacological denervation.
Topics: 5-Hydroxytryptophan; Animals; Atropine; Behavior, Animal; Denervation; Drug Tolerance; Humans; Methysergide; Mice; Morphine Dependence; Pentobarbital; Physostigmine; Receptors, Cholinergic; Receptors, Serotonin; Substance Withdrawal Syndrome | 1978 |
Cholinergic link in yawning.
Topics: Animals; Cholinergic Fibers; Female; Haplorhini; Humans; Male; Mouth; Naloxone; Papio; Physostigmine; Reflex; Substance Withdrawal Syndrome | 1978 |
[Effect of psychotomimetics and haloperidol on head twitching following alcohol withdrawal in mice].
Topics: Animals; Ethanol; Hallucinogens; Haloperidol; Humans; Lysergic Acid Diethylamide; Male; Mescaline; Mice; Physostigmine; Substance Withdrawal Syndrome; Tremor | 1978 |
Morphine tolerance and physical dependence: influence of cholinergic agonists and antagonists.
Topics: Acetylcholine; Analgesia; Animals; Atropine; Brain; Choline; Drug Synergism; Drug Tolerance; Humans; Male; Mice; Morphine Dependence; Motor Activity; Naloxone; Parasympatholytics; Parasympathomimetics; Physostigmine; Scopolamine; Substance Withdrawal Syndrome | 1976 |
Effects of cholinergic and anticholinergic drugs and a partial cholinergic agonist on the development and expression of physical dependence on morphine in rat.
Topics: Animals; Atropine; Body Weight; Choline; Humans; Male; Mecamylamine; Morphine Dependence; Parasympatholytics; Parasympathomimetics; Physostigmine; Rats; Substance Withdrawal Syndrome; Time Factors | 1975 |
Morphine withdrawal response and central cholinergic activity.
Topics: Acetylcholine; Animals; Atropine; Humans; Male; Morphine Dependence; Naloxone; Parasympathetic Nervous System; Physostigmine; Rats; Receptors, Cholinergic; Substance Withdrawal Syndrome | 1975 |
Endocrine, immune, and neurochemical changes in rats during withdrawal from chronic amphetamine intoxication.
Topics: Adrenocorticotropic Hormone; Amphetamine; Animals; Biomarkers; Body Weight; Brain Chemistry; Corticotropin-Releasing Hormone; Depressive Disorder; Endocrine Glands; Immune System; In Vitro Techniques; Killer Cells, Natural; Male; Physostigmine; Prolactin; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome | 1991 |
[Central anticholinergic syndrome in intensive care patients].
Topics: Arousal; Brain; Critical Care; Female; Humans; Male; Middle Aged; Parasympatholytics; Physostigmine; Psychoses, Substance-Induced; Receptors, Cholinergic; Receptors, Muscarinic; Substance Withdrawal Syndrome; Ventilator Weaning | 1991 |
Effects of specific mu and kappa opiate tolerance and abstinence on hypothalamo-pituitary-adrenal axis secretion in the rat.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adrenocorticotropic Hormone; Analgesics; Animals; Circadian Rhythm; Corticosterone; Dose-Response Relationship, Drug; Drug Tolerance; Hypothalamo-Hypophyseal System; Male; Morphine; Narcotics; Parasympathomimetics; Physostigmine; Pituitary-Adrenal System; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Serotonin; Stress, Physiological; Substance Withdrawal Syndrome | 1990 |
Physostigmine induced beta-endorphin release as a mechanism for physostigmine management of early alcohol withdrawal.
Topics: beta-Endorphin; Ethanol; Humans; Models, Biological; Physostigmine; Substance Withdrawal Syndrome | 1989 |
Local physostigmine in the management of early alcohol withdrawal.
Topics: Adult; Alcoholism; Double-Blind Method; Humans; Male; Ophthalmic Solutions; Physostigmine; Substance Withdrawal Syndrome | 1987 |
Physostigmine in alcohol withdrawal: a new clinical approach.
Topics: Adult; Carbamazepine; Drug Therapy, Combination; Ethanol; Humans; Male; Middle Aged; Ophthalmic Solutions; Physostigmine; Substance Withdrawal Syndrome | 1986 |
Harmine-, LON-954- and 5-hydroxytryptophan-induced tremors in rats withdrawn from ethanol.
Topics: 5-Hydroxytryptophan; Alkaloids; Animals; Ethanol; Harmine; Male; Physostigmine; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Tremor; Urea | 1985 |
Cholinergic agents: antinociception without morphine type dependence in rats.
Topics: Analgesics; Animals; Body Weight; Drug Interactions; Humans; Male; Morphine; Oxotremorine; Physostigmine; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Substance-Related Disorders | 1985 |
Changes in physostigmine-induced hippocampal seizures during ethanol withdrawal.
Topics: Animals; Electroencephalography; Ethanol; Hippocampus; Humans; Male; Physostigmine; Rats; Rats, Inbred Strains; Seizures; Substance Withdrawal Syndrome | 1985 |
Ethanol withdrawal tremor does not interact with physostigmine-induced tremor in rat.
Topics: Animals; Arecoline; Atropine; Ethanol; Male; Physostigmine; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Time Factors; Tremor | 1985 |
Alcohol withdrawal reactions in mice: effects of drugs that modify neurotransmission.
Topics: 5-Hydroxytryptophan; Acetates; Aminobutyrates; Animals; Atropine; Ethanol; Fenclonine; Humans; Male; Methyltyrosines; Mice; Neurotransmitter Agents; Nialamide; Phentolamine; Physostigmine; Picrotoxin; Propranolol; Pyrazoles; Reserpine; Serotonin; Substance Withdrawal Syndrome; Time Factors; Tryptophan | 1973 |
Modification of precipitated morphine withdrawal syndrome by drugs affecting cholinergic mechanisms.
Topics: Animals; Atropine; Autonomic Nervous System; Diphenhydramine; Dose-Response Relationship, Drug; Drug Synergism; Humans; Imipramine; Mecamylamine; Morphine; Morphine Dependence; Naloxone; Neurotransmitter Agents; Physostigmine; Propranolol; Rats; Receptors, Adrenergic; Receptors, Cholinergic; Substance Withdrawal Syndrome; Synaptic Transmission; Tolazoline | 1973 |
Neuroanatomical and chemical correlates of naloxone-precipitated withdrawal.
Topics: Animals; Behavior, Animal; Biogenic Amines; Brain; Brain Chemistry; Brain Stem; Cerebellum; Cerebral Cortex; Dopamine; Dose-Response Relationship, Drug; Humans; Hypothalamus; Mice; Morphine Dependence; Naloxone; Norepinephrine; Physostigmine; Serotonin; Stereotaxic Techniques; Stereotyped Behavior; Substance Withdrawal Syndrome; Thalamus; Time Factors; Tubocurarine | 1973 |
Elevation of brain dopamine during naloxone-precipitated withdrawal in morphine-dependent mice and rats.
Topics: Animals; Atropine; Brain; Brain Stem; Cerebellum; Corpus Striatum; Dopamine; Humans; Hypothalamus; Male; Mice; Morphine Dependence; Naloxone; Norepinephrine; Pargyline; Physostigmine; Placebos; Rats; Reserpine; Serotonin; Stereotyped Behavior; Substance Withdrawal Syndrome; Time Factors; Tubocurarine | 1973 |
Pharmacologic analysis of the hypothermic responses of the morphine-dependent rhesus monkey.
Topics: Animals; Atropine; Body Temperature Regulation; Cholinesterase Inhibitors; Female; Haplorhini; Humans; Macaca; Male; Morphine; Morphine Dependence; Nalorphine; Neostigmine; Parasympathomimetics; Physostigmine; Substance Withdrawal Syndrome; Time Factors; Tropanes | 1971 |